CTC
LLY icon

Central Trust Company’s Eli Lilly LLY Stock Holding History

Central Trust Company’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.3M Sell
41,630
-266
-0.6% -$270K 0.75% 30
2025
Q4 		$45M Sell
41,896
-1,423
-3% -$1.36M 0.88% 28
2025
Q3 		$33.1M Sell
43,319
-632
-1% -$470K 0.69% 32
2025
Q2 		$34.3M Buy
43,951
+190
+0.4% +$148K 0.79% 28
2025
Q1 		$36.1M Sell
43,761
-1,319
-3% -$1.1M 0.89% 29
2024
Q4 		$34.8M Sell
45,080
-224
-0.5% -$185K 0.85% 29
2024
Q3 		$40.1M Buy
45,304
+858
+2% +$771K 0.94% 28
2024
Q2 		$40.2M Sell
44,446
-1,175
-3% -$940K 0.99% 24
2024
Q1 		$35.5M Sell
45,621
-589
-1% -$419K 0.88% 29
2023
Q4 		$26.9M Sell
46,210
-962
-2% -$562K 0.72% 34
2023
Q3 		$25.3M Buy
47,172
+422
+0.9% +$217K 0.73% 37
2023
Q2 		$21.9M Buy
46,750
+46
+0.1% +$19.3K 0.61% 40
2023
Q1 		$16M Sell
46,704
-1,158
-2% -$391K 0.47% 45
2022
Q4 		$17.5M Buy
47,862
+5,062
+12% +$1.79M 0.54% 41
2022
Q3 		$13.8M Buy
42,800
+1,582
+4% +$501K 0.47% 47
2022
Q2 		$13.4M Sell
41,218
-269
-0.6% -$80.7K 0.44% 50
2022
Q1 		$11.9M Sell
41,487
-195
-0.5% -$50.2K 0.34% 59
2021
Q4 		$11.5M Sell
41,682
-9
-0% -$2.28K 0.32% 63
2021
Q3 		$9.63M Buy
41,691
+31
+0.1% +$7.65K 0.34% 67
2021
Q2 		$9.56M Sell
41,660
-251
-0.6% -$50.4K 0.35% 71
2021
Q1 		$7.83M Sell
41,911
-1,110
-3% -$217K 0.31% 79
2020
Q4 		$7.26M Buy
43,021
+82
+0.2% +$12.2K 0.3% 78
2020
Q3 		$6.36M Buy
42,939
+3,548
+9% +$549K 0.29% 81
2020
Q2 		$6.47M Sell
39,391
-1,289
-3% -$198K 0.32% 73
2020
Q1 		$5.64M Sell
40,680
-975
-2% -$134K 0.35% 71
2019
Q4 		$5.47M Sell
41,655
-1,080
-3% -$125K 0.28% 86
2019
Q3 		$4.78M Sell
42,735
-10,296
-19% -$1.15M 0.27% 97
2019
Q2 		$5.82M Sell
53,031
-949
-2% -$112K 0.33% 72
2019
Q1 		$7M Buy
53,980
+983
+2% +$120K 0.42% 60
2018
Q4 		$6.13M Sell
52,997
-106
-0.2% -$11.8K 0.41% 59
2018
Q3 		$5.7M Buy
53,103
+886
+2% +$88.6K 0.33% 74
2018
Q2 		$4.46M Buy
52,217
+534
+1% +$43.9K 0.28% 87
2018
Q1 		$4M Sell
51,683
-8,044
-13% -$648K 0.25% 94
2017
Q4 		$5.04M Sell
59,727
-1,585
-3% -$135K 0.31% 81
2017
Q3 		$5.25M Sell
61,312
-1,395
-2% -$114K 0.34% 75
2017
Q2 		$5.16M Sell
62,707
-4,028
-6% -$329K 0.34% 81
2017
Q1 		$5.61M Buy
66,735
+13,260
+25% +$1.06M 0.37% 72
2016
Q4 		$3.93M Buy
53,475
+23,007
+76% +$1.71M 0.27% 100
2016
Q3 		$2.45M Buy
30,468
+5,253
+21% +$420K 0.18% 137
2016
Q2 		$1.99M Sell
25,215
-350
-1% -$26.4K 0.15% 146
2016
Q1 		$1.84M Sell
25,565
-9,087
-26% -$688K 0.15% 150
2015
Q4 		$2.92M Buy
34,652
+2,316
+7% +$192K 0.24% 103
2015
Q3 		$2.71M Buy
32,336
+853
+3% +$72K 0.24% 111
2015
Q2 		$2.63M Sell
31,483
-470
-1% -$35.8K 0.21% 120
2015
Q1 		$2.32M Sell
31,953
-2,664
-8% -$190K 0.19% 124
2014
Q4 		$2.39M Buy
34,617
+70
+0.2% +$4.72K 0.19% 124
2014
Q3 		$2.24M Sell
34,547
-4,030
-10% -$255K 0.18% 134
2014
Q2 		$2.4M Buy
38,577
+19,741
+105% +$1.18M 0.19% 131
2014
Q1 		$1.11M Buy
18,836
+853
+5% +$47.6K 0.09% 197
2013
Q4 		$917K Buy
17,983
+1,420
+9% +$71.1K 0.08% 217
2013
Q3 		$834K Buy
16,563
+1,275
+8% +$66.7K 0.08% 218
2013
Q2 		$750K Buy
+15,288
New +$832K 0.07% 223

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Central Trust Company's LLY Position: Q1 2026 in Review

Central Trust Company reduced its Eli Lilly (LLY) stake by 0.63% in Q1 2026, selling an estimated $270K and leaving 41,630 shares worth $38.3M. The position accounts for 0.75% of the portfolio, ranked #30.

Central Trust Company first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $45M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Central Trust Company held 41,630 shares of Eli Lilly worth $38.3M as of Q1 2026.
  • Central Trust Company sold 266 Eli Lilly shares in Q1 2026, an estimated $270K.
  • Eli Lilly made up 0.75% of Central Trust Company's portfolio in Q1 2026, its #30 holding.
  • Central Trust Company first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Central Trust Company's Eli Lilly position peaked at $45M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.